These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23334989)

  • 21. Differences in gastrointestinal calcium absorption after the ingestion of calcium-free phosphate binders.
    Behets GJ; Dams G; Damment SJ; Martin P; De Broe ME; D'Haese PC
    Am J Physiol Renal Physiol; 2014 Jan; 306(1):F61-7. PubMed ID: 24197066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of lanthanum carbonate on phosphate control in continuous ambulatory peritoneal dialysis patients in Korea: a randomized prospective study.
    Lee YK; Choi HY; Shin SK; Lee HY
    Clin Nephrol; 2013 Feb; 79(2):136-42. PubMed ID: 23211335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lanthanum Carbonate - A New Phosphate Binding Drug in Advanced Renal Failure.
    Aaseth J; Bjorke-Monsen AL
    Curr Med Chem; 2018; 25(1):113-117. PubMed ID: 28486924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Removal of phosphate from polluted water by lanthanum doped vesuvianite.
    Li H; Ru J; Yin W; Liu X; Wang J; Zhang W
    J Hazard Mater; 2009 Aug; 168(1):326-30. PubMed ID: 19297092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy, tolerability, and safety of lanthanum carbonate in hyperphosphatemia: a 6-month, randomized, comparative trial versus calcium carbonate.
    Hutchison AJ; Maes B; Vanwalleghem J; Asmus G; Mohamed E; Schmieder R; Backs W; Jamar R; Vosskuhler A
    Nephron Clin Pract; 2005; 100(1):c8-19. PubMed ID: 15809508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate.
    Yang Y; Mohammad A; Berendt RT; Carlin A; Khan MA; Faustino PJ
    J Pharm Sci; 2016 Feb; 105(2):864-875. PubMed ID: 26219932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improving phosphate-binder therapy as a way forward.
    Hutchison AJ
    Nephrol Dial Transplant; 2004 Mar; 19 Suppl 1():i19-24. PubMed ID: 15126650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of dietary phosphate absorption after single doses of lanthanum carbonate and sevelamer carbonate in healthy volunteers: a balance study.
    Martin P; Wang P; Robinson A; Poole L; Dragone J; Smyth M; Pratt R
    Am J Kidney Dis; 2011 May; 57(5):700-6. PubMed ID: 21354682
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term efficacy and tolerability of lanthanum carbonate: results from a 3-year study.
    Hutchison AJ; Maes B; Vanwalleghem J; Asmus G; Mohamed E; Schmieder R; Backs W; Jamar R; Vosskühler A
    Nephron Clin Pract; 2006; 102(2):c61-71. PubMed ID: 16224198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reducing high phosphate levels in patients with chronic renal failure undergoing dialysis: a 4-week, dose-finding, open-label study with lanthanum carbonate.
    Hutchison AJ; Speake M; Al-Baaj F
    Nephrol Dial Transplant; 2004 Jul; 19(7):1902-6. PubMed ID: 15199195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the potential genotoxicity of the phosphate binder lanthanum carbonate.
    Damment SJ; Beevers C; Gatehouse DG
    Mutagenesis; 2005 Jan; 20(1):29-37. PubMed ID: 15625069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. One year efficacy and safety of lanthanum carbonate for hyperphosphatemia in Japanese chronic kidney disease patients undergoing hemodialysis.
    Shigematsu T;
    Ther Apher Dial; 2010 Feb; 14(1):12-9. PubMed ID: 20438515
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonate.
    Behets GJ; Verberckmoes SC; Oste L; Bervoets AR; Salomé M; Cox AG; Denton J; De Broe ME; D'Haese PC
    Kidney Int; 2005 May; 67(5):1830-6. PubMed ID: 15840030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive function in Stage 5 chronic kidney disease patients on hemodialysis: no adverse effects of lanthanum carbonate compared with standard phosphate-binder therapy.
    Altmann P; Barnett ME; Finn WF;
    Kidney Int; 2007 Feb; 71(3):252-9. PubMed ID: 17035945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coupled catalytic dephosphorylation and complex phosphate ion-exchange in networked hierarchical lanthanum carbonate grafted asymmetric bio-composite membrane.
    Srivastava AK; Kaundal B; Sardoiwala MN; Choudhury SR; Karmakar S
    J Colloid Interface Sci; 2022 Jan; 606(Pt 2):2024-2037. PubMed ID: 34749449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lanthanum carbonate.
    Joy MS; Kshirsagar A; Candiani C; Brooks T; Hudson JQ
    Ann Pharmacother; 2006 Feb; 40(2):234-40. PubMed ID: 16449551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of continuous oral administration of lanthanum carbonate over 24 months.
    Ishizu T; Hong Z; Matsunaga T; Kaneko Y; Taru Y
    Ther Apher Dial; 2013 Apr; 17 Suppl 1():22-8. PubMed ID: 23586509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adsorption behavior of phosphate on lanthanum(III)-coordinated diamino-functionalized 3D hybrid mesoporous silicates material.
    Zhang J; Shen Z; Shan W; Mei Z; Wang W
    J Hazard Mater; 2011 Feb; 186(1):76-83. PubMed ID: 21131125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a La(III)-modified bentonite for effective phosphate removal from aqueous media.
    Kuroki V; Bosco GE; Fadini PS; Mozeto AA; Cestari AR; Carvalho WA
    J Hazard Mater; 2014 Jun; 274():124-31. PubMed ID: 24769849
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Control of serum phosphate by oral lanthanum carbonate in patients undergoing haemodialysis and continuous ambulatory peritoneal dialysis in a short-term, placebo-controlled study.
    Al-Baaj F; Speake M; Hutchison AJ
    Nephrol Dial Transplant; 2005 Apr; 20(4):775-82. PubMed ID: 15703206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.